4.4 Article

Conjugating heparin, Arg-Glu-Asp-Val peptide, and anti-CD34 to the silanic Mg-Zn-Y-Nd alloy for better endothelialization

期刊

JOURNAL OF BIOMATERIALS APPLICATIONS
卷 35, 期 2, 页码 158-168

出版社

SAGE PUBLICATIONS LTD
DOI: 10.1177/0885328220926655

关键词

Cardiovascular stent materials; biodegradable magnesium; corrosion resistance; pro-endothelialization; surface modification

资金

  1. Key Projects of the Joint Fund of the National Natural Science Foundation of China [U1804251]
  2. National Key Research and Development Program of China [2018YFC1106703, 2017YFB0702500, 2016YFC1102403]
  3. National Natural Science Foundation of China [NSFC51671175]
  4. Top Doctor Program of Zhengzhou University [32210475]

向作者/读者索取更多资源

Magnesium alloy is generally accepted as a potential cardiovascular stent material due to its good mechanical properties, biocompatibility, and biodegradability, and has become one of the research hotspots in this field. However, too fast degradation rate and delayed surface endothelialization have been the bottleneck of further application of magnesium alloy stent. In this study, we selected Mg-Zn-Y-Nd, a kind of biodegradable magnesium alloy for cardiovascular stent, and passivated its surface by alkali heat treatment and silane treatment to improve the corrosion resistance, subsequently conjugated Arg-Glu-Asp-Val (REDV) peptide and anti-CD34 to promote endothelial cells adhesion and capture endothelial progenitor cells respectively, further improving surface endothelialization. In addition, the heparin was also immobilized to the Mg-Zn-Y-Nd surface for the consideration of anti-coagulation and anti-inflammation. Systematic material characterization and biological evaluation show that we have successfully developed this composite surface on Mg-Zn-Y-Nd alloy, and achieved multiple functions such as corrosion resistance, promoting endothelialization, and inhibiting platelet/macrophage adhesion.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据